Vitality Watch

Dossier clinicaltrials trial early 28-jul-2026
Small or early-phase human trial or pilot study

Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women

Key claim: This study aims to test whether vascular beta3-adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and improve vascular function.

Abstract

To determine if vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and enhance vascular function in aging women.

Why this matters

This study aims to test whether vascular beta3-adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and improve vascular function.

Source

Link

Briefing card

Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women
Stage: trial early · clinicaltrials · 28-jul-2026

This study aims to test whether vascular beta3-adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and improve vascular function.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07674680

build build 880 · 2bcef25 · 2026-11-18